Catalyst Wire Dossier Catalyst Wire Dossier

Pegaptanib Sodium

pegaptanib · Pfizer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegaptanib Sodium, covering 2013-09-06 to 2013-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema [Phase 3]

See pricing